The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women
Abstract
BACKGROUND: While high-sensitivity C-reactive protein (hsCRP) is an independent predictor of cardiovascular risk, global risk prediction models incorporating hsCRP have not been developed for clinical use. OBJECTIVE: To develop and compare global cardiovascular risk prediction models with and without hsCRP. DESIGN: Observational cohort study. SETTING: U.S. female health professionals. PARTICIPANTS: Initially healthy nondiabetic women age 45 years and older participating in the Women's Health Study and followed an average of 10 years. MEASUREMENTS: Incident cardiovascular events (myocardial infarction, stroke, coronary revascularization, and cardiovascular death). RESULTS: High-sensitivity CRP made a relative contribution to global risk at least as large as that provided by total, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol individually, but less than that provided by age, smoking, and blood pressure. All global measures of fit improved when hsCRP was included, with likelihood-based measures demonstrating strong preference for models that include hsCRP. With use of 10-year risk categories of 0% to less than 5%, 5% to less than 10%, 10% to less than 20%, and 20% or greater, risk prediction was more accurate in models that included hsCRP, particularly for risk between 5% and 20%. Among women initially classified with risks of 5% to less than 10% and 10% to less than 20% according to the Adult Treatment Panel III covariables, 21% and 19%, respectively, were reclassified into more accurate risk categories. Although addition of hsCRP had minimal effect on the c-statistic (a measure of model discrimination) once age, smoking, and blood pressure were accounted for, the effect was nonetheless greater than that of total, LDL, or HDL cholesterol, suggesting that the c-statistic may be insensitive in evaluating risk prediction models. LIMITATIONS: Data were available only for women. CONCLUSIONS: A global risk prediction model that includes hsCRP improves cardiovascular risk classification in women, particularly among those with a 10-year risk of 5% to 20%. In models that include age, blood pressure, and smoking status, hsCRP improves prediction at least as much as do lipid measures.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CRP has emerged as a particularly stronger independent risk factor for cardiovascular disease than the low-density lipoprotein cholesterol level [13, 33, 34].”
From Exercise as a Mean to Control Low‐Grade Systemic Inflammation (2008) · cites this paper as [33]
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Research works printed but not linked: 3
- Buring JE, 1992, Journal of Myocardial Ischemia, 4, 27
- Nagelkerke NJ, 1991, Biomka, 78, 691
- Boekholdt SM, 2005, Atherosclerosis
Cited by
Sorted by citations
Items 301–400 of 503
Biomarkers of atherosclerosis: Clinical applications
Brown, T. M., & Bittner, V. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-009-0005-z · Cited by 15
Clinical Utility of Novel Biomarkers in the Prediction of Coronary Heart Disease
Kim, H. C. (2012) · Korean Circulation Journal · doi:10.4070/kcj.2012.42.4.223 · Cited by 15
Hamer, M., Chida, Y., & Stamatakis, E. A. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.020 · Cited by 15
Schonberger, R. B., Dai, F., Brandt, C., & Burg, M. M. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000860 · Cited by 15
Clinical Significance of High-Sensitivity C-Reactive Protein in Cardiovascular Disease
Conen, D., & Ridker, P. M. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.2.229 · Cited by 16
A clinical predictive model of renal injury in children with isolated antenatal hydronephrosis
Costa, F. P., Silva, A. C. S. E., MAK, R. H. K., Ix, J. H., Vasconcelos, M. A., Dias, C. S., Fonseca, C. C., Oliveira, M. C. L., & OLIVEIRA, E. A. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz102 · Cited by 14
Cardiovascular disease screening
Duffy, J. Y., & Hameed, A. B. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.05.004 · Cited by 14
Flores, M., Barquera, S., Carrión, C., Rojas, R., Villalpando, S., Olaiz-Fernández, G., & González‐Villalpando, C. (2007) · Salud Pública de México · doi:10.1590/s0036-36342007000900006 · Cited by 14
The role of dietary polyunsaturated fatty acids in inflammation
Vučić, V. (2013) · Serbian Journal of Experimental and Clinical Research · doi:10.5937/sjecr14-4774 · Cited by 14
The Need for Individualized Risk Assessment in Cardiovascular Disease
Lim, H. Y., Burrell, L. M., Brook, R., Nandurkar, H. H., Donnan, G. A., & Ho, P. W. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12071140 · Cited by 14
Quantifying the value of biomarkers for predicting mortality
Goldman, N., & Glei, D. A. (2015) · Annals of Epidemiology · doi:10.1016/j.annepidem.2015.08.008 · Cited by 14
Assessment of Cardiovascular Risk
Cooney, M. T., Cooney, H. C., Dudina, A. L., & Graham, I. M. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0143-1 · Cited by 15
Nambi, V., & Ballantyne, C. M. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0034-8 · Cited by 14
Disparities in Women's Cardiovascular Health
McSweeney, J. C., Bricker, C., Souder, E., & Rhoads, S. (2011) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.2011.01239.x · Cited by 13
Comment: Measures to Summarize and Compare the Predictive Capacity of Markers
Cook, N. R. (2010) · The International Journal of Biostatistics · doi:10.2202/1557-4679.1257 · Cited by 13
Welsh, P. I., Packard, C. J., & Sattar, N. A. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32831551e0 · Cited by 14
Kizer, J. R., Krauser, D. G., Rodeheffer, R. J., Burnett, J. C. J., Okin, P. M., Roman, M. J., Umans, J. G., Best, L. G., Lee, E. T., & Devereux, R. B. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.03.026 · Cited by 13
Macleod, J., Metcalfe, C. D., Smith, G. D., & Hart, C. (2007) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2006.055921 · Cited by 13
Uno, H., Cai, T., Tian, L., & Wei, L.-J. (2011) · Biometrics · doi:10.1111/j.1541-0420.2011.01600.x · Cited by 10
Tokgözoğlu, L. S., Morrow, D. A., & Nicholls, S. J. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad275 · Cited by 12
Evaluation of C-Reactive Protein in Primary and Secondary Prevention
Corrado, E., & Novo, S. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.00023 · Cited by 12
Epidemiology of Coronary Heart Disease in the Elderly
Vokonas, P., & Kannel, W. B. (2008) · Fundamental and clinical cardiology · doi:10.3109/9781420061710.008 · Cited by 12
Total cardiovascular disease risk assessment
Cooney, M. T., Cooney, H. C., Dudina, A. L., & Graham, I. M. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283499f06 · Cited by 13
Prediction of Cardiovascular Disease Events
Wilson, P. W. F. (2010) · Cardiology Clinics · doi:10.1016/j.ccl.2010.10.004 · Cited by 13
Huang, Y., & Pepe, M. S. (2010) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/j.1467-9876.2009.00707.x · Cited by 11
Gray, K. E., Kapp-Simon, K., Starr, J. R., Collett, B., Wallace, E. R., & Speltz, M. L. (2014) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12643 · Cited by 8
Evaluating the Prognostic Value of New Cardiovascular Biomarkers
Wood, A., & Greenland, P. (2009) · Disease Markers · doi:10.1155/2009/412947 · Cited by 11
Evaluación de la inflamación en el laboratorio
Naranjo, L. A. G., & Restrepo, J. F. M. (2010) · Revista Colombiana de Reumatología · doi:10.1016/s0121-8123(10)70091-8 · Cited by 11
Predicting fracture risk: Tougher than it looks
Browner, W. S. (2007) · BoneKEy-Osteovision · doi:10.1138/20070269 · Cited by 11
Fan, J.-S., Wang, M., Chen, N., Sun, B.-C., Zhang, Q.-B., Li, Y., & Huang, M.-J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1204727 · Cited by 11
Biomarkers for Coronary Heart Disease Clinical Risk Prediction: A Critical Appraisal
Wilkins, J. T., & Lloyd‐Jones, D. M. (2010) · Preventive Cardiology · doi:10.1111/j.1751-7141.2010.00081.x · Cited by 10
Ingle, L., Carroll, S., Stamatakis, E. A., & Hamer, M. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.001 · Cited by 10
New Risk Markers for Cardiovascular Prevention
Backer, G. D. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0427-z · Cited by 11
Novel cardiovascular risk markers in women with ischaemic heart disease : review article
Pop, D., Dǎdârlat, A., & Zdrenghea, M. (2014) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2014-014 · Cited by 10
Bushnell, G., Brookhart, M. A., Gaynes, B. N., Compton, S. N., Dusetzina, S. B., & Stürmer, T. (2018) · Medical Care · doi:10.1097/mlr.0000000000000911 · Cited by 10
Leoce, N., Jin, Z., Kehm, R. D., Roh, J. M., Laurent, C. A., Kushi, L. H., & Terry, M. B. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01469-w · Cited by 10
[Prevalence of metabolic syndrome in health employees].
Padierna-Luna, J. L., Ochoa-Rosas, F. S., & Jaramillo-Villalobos, B. (2007) · PubMed · Cited by 10
Nylander, R., Lind, L., Wikström, J., Lindahl, B., Venge, P., Larsson, A. O., Ärnlöv, J., Berglund, L., Ahlström, H. K., Johansson, L., et al. (2014) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.08.027 · Cited by 10
Geographic Variation in Cardiovascular Inflammation among Healthy Women in the Women's Health Study
Clark, C. R., Coull, B. A., Berkman, L. F., Buring, J. E., & Ridker, P. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027468 · Cited by 10
C-reactive protein and target organ damage in untreated patients with primary hypertension
Ratto, E., Leoncini, G., Viazzi, F. C., Falqui, V., Parodi, A., Conti, N. E., Tomolillo, C., Deferrari, G., & Pontremoli, R. (2007) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2007.09.003 · Cited by 10
Poltavskiy, E. A., Spence, J. D., Kim, J., & Bang, H. (2016) · Online Journal of Public Health Informatics · doi:10.5210/ojphi.v8i2.6643 · Cited by 10
Adopting nested case–control quota sampling designs for the evaluation of risk markers
Zheng, Y., Cai, T., & PEPE, M. S. (2013) · Lifetime Data Analysis · doi:10.1007/s10985-013-9270-8 · Cited by 10
Park, H. (2022) · Healthcare · doi:10.3390/healthcare10020361 · Cited by 9
Reclassification of predictions for uncovering subgroup specific improvement
Biswas, S., Arun, B. K., & Parmigiani, G. (2013) · Statistics in Medicine · doi:10.1002/sim.6077 · Cited by 9
Öztaş, E., & Kurtay, G. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1292-9 · Cited by 9
Garadah, T. S., Jaradat, A., Al‐Alawi, M., Hassan, A. B., & Sequeira, R. P. (2016) · Journal of Blood Medicine · doi:10.2147/jbm.s114585 · Cited by 9
Gender aspects in patients with angina and unobstructed coronary arteries
Ong, P., Athanasiadis, A., & Sechtem, U. P. (2013) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-013-0058-x · Cited by 8
Davis, M. B., & Duvernoy, C. S. (2011) · Women s Health · doi:10.2217/whe.11.34 · Cited by 9
Saran, K. A., Sabry, A. A.-A., Shalaby, M., Sherbeiny, S. A., & Morad, M. A. (2012) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2012.01116.x · Cited by 9
Goldhaber, S. Z. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00012 · Cited by 9
The Latest and Greatest New Biomarkers
de Lemos, J. A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2428 · Cited by 9
Statistically Significant Association Does not Imply Improvement in Prediction of Clinical Outcomes
Jiang, S., ROSNER, B. A., & Colditz, G. A. (2025) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-25-0056 · Cited by 9
New weighting methods when cases are only a subset of events in a nested case‐control study
Zhou, Q. M., Wang, X., Zheng, Y., & Cai, T. (2022) · Biometrical Journal · doi:10.1002/bimj.202100194 · Cited by 8
Use of In Vitro Fertilisation Prediction Model in an Asian Population—Experience in Singapore
Saha, L., Fook-Chong, S. M. C., Rajesh, H., Chia, D. S., & Yu, S. L. (2015) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v44n11p524 · Cited by 8
Factor VII-activating protease
Ramanathan, R., Gram, J., Sand, N. P. R., Nørgaard, B. L., Diederichsen, A. C. P., Vitzthum, F., Schwarz, H., & Sidelmann, J. J. (2017) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000640 · Cited by 8
Risk of Adverse Cardiovascular Outcomes in Postmenopausal Women with Inflammatory Bowel Disease
Greywoode, R., Larson, J. C., Peraza, J., Clark, R., Allison, M., Chaudhry, N. A., Schnatz, P. F., Shadyab, A. H., Wallace, R. B., & Wassertheil‐Smoller, S. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08348-2 · Cited by 7
Discordances among different tools used to estimate cardiovascular risk in postmenopausal women
Pelletier, P., Lapointe, A., Laflamme, N., Piché, M., Weisnagel, S. J., Nadeau, A., Lemieux, S., & Bergeron, J. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70535-5 · Cited by 7
Chao, T.-H., Lin, T., Cheng, C., Wu, Y., Ueng, K., Wu, Y., Lin, W.-W., Leu, H.-B., Cheng, H., Huang, C., et al. (2024) · PubMed Central · doi:10.6515/acs.202409_40(5).20240724a · Cited by 7
Stewart, R. (2009) · Future Cardiology · doi:10.2217/fca.09.8 · Cited by 7
COMPARING RISK SCORING SYSTEMS BEYOND THE ROC PARADIGM IN SURVIVAL ANALYSIS
Uno, H., Tian, L., Cai, T., Tian, L., Cai, T., Kohane, I. S., & Wei, L. J. (2009) · Cited by 7
Smith, S. C., Taylor, A. J., Weintraub, W. S., Kushner, F. G., Lauer, M. S., Benjamin, J. M., Budoff, M. J., Fayad, Z. A., Foster, E., Greenland, P., et al. (2011) · Cited by 7
Cardiometabolic Risk Among African American Women
Appel, S. J., Oster, R. A., Floyd, N. A., & Ovalle, F. (2009) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e318197aa3a · Cited by 7
How to identify patients with vulnerable plaques
Virani, S. S., & Ballantyne, C. M. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00812.x · Cited by 7
Risk Factors, Risk Prediction, and the Apolipoprotein B–Apolipoprotein A-I Ratio
Berkwits, M., & Güallar, E. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00012 · Cited by 7
Woloshin, S., Schwartz, L. M., Kerin, K. M. C., & Welch, H. G. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0033-z · Cited by 6
Mathematical modelling and its application to social care
Squires, H., & Tappenden, P. (2011) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · Cited by 7
Cohen-Heyman, N., & Chodick, G. (2025) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2025.200363 · Cited by 6
Comparing costs associated with risk stratification rules for t-year survival
Cai, T., Tian, L., & Lloyd‐Jones, D. M. (2011) · Biostatistics · doi:10.1093/biostatistics/kxr001 · Cited by 6
Cautionary tales in the interpretation of studies of tools for predicting risk and prognosis
Scott, I. A., & Greenberg, P. B. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2010.02210.x · Cited by 6
Evaluating subject-level incremental values of new markers for risk classification rule
Cai, T., Tian, L., Lloyd‐Jones, D. M., & Wei, L. J. (2013) · Lifetime Data Analysis · doi:10.1007/s10985-013-9272-6 · Cited by 6
Chu, J. W., Jones, G. T., Tarr, G. P., Phillips, L. V., WILKINS, G. T., van Rij, A. M., & Williams, M. J. A. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.12.093 · Cited by 6
Inflammasjon og C-reaktivt protein ved hjerte- og karsykdom
Munk, P. L., & Larsen, A. I. (2009) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.08.0011 · Cited by 6
Busch, E. L., Don, P. K., Chu, H., Richardson, D. B., Keku, T. O., Eberhard, D. A., Avery, C. L., & Sandler, R. S. (2018) · BMC Cancer · doi:10.1186/s12885-017-3964-3 · Cited by 6
Demler, O., Paynter, N. P., & Cook, N. R. (2018) · Diagnostic and Prognostic Research · doi:10.1186/s41512-018-0034-5 · Cited by 6
Optimizing Risk Stratification and Noninvasive Diagnosis of Ischemic Heart Disease in Women
Garuba, H. A., Erthal, F., Stadnick, E., Alzahrani, A., Chow, B. J. W., deKemp, R. A., & Beanlands, R. S. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.01.026 · Cited by 6
C-Reactive Protein: The Harbinger of Cardiovascular Diseases
Abi‐Saleh, B., Iskandar, S. B., Elgharib, N. Z., & Cohen, M. V. (2008) · Southern Medical Journal · doi:10.1097/smj.0b013e31816c0195 · Cited by 6
Symptomer og diagnostikk av koronarsykdom hos kvinner
Halvorsen, S., & Risöe, C. (2009) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.09.0115 · Cited by 6
Căținaș, R., & Hostiuc, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146818 · Cited by 5
Lusk, J. B., O'Brien, E. C., Hammill, B. G., Li, F., Grory, B. M., Patel, M. R., Pagidipati, N. J., & Shah, N. P. (2025) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.124.004629 · Cited by 5
Proteína C reactiva y enfermedad arterial coronaria
Álvarez, F. D. L. C. H., González, A. P., Dopico, R. R., & Grek, O. G. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 5
Biomarkers and Bioassays for Cardiovascular Diseases: Present and Future.
Sim, D., Lieu, H. D., & André, P. (2008) · PubMed Central · Cited by 5
Stuenkel, C. A. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181ff3e96 · Cited by 5
Countouris, M. E., Demirci, J. R., Jeyabalan, A., Catov, J. M., & Schwarz, E. B. (2019) · Breastfeeding Medicine · doi:10.1089/bfm.2018.0153 · Cited by 5
Seo, J., Choi, S. I., & Kim, Y. K. (2019) · Korean Journal of Radiology · doi:10.3348/kjr.2018.0016 · Cited by 5
Talari, H. R., Bahrami, M., Ardestani, A. T., Bahmani, F., Famili, P., & Asemi, Z. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_152_18 · Cited by 5
A Patient-Centered Methodology That Improves the Accuracy of Prognostic Predictions in Cancer
Kashani–Sabet, M., Sagebiel, R. W., Joensuu, H., & Miller, J. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056435 · Cited by 5
Ullah, R., Khan, M., Huang, Y., & Wang, G. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1600695 · Cited by 4
Biostatistics behind risk prediction models
Kaushal, K., & Raina, S. K. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2406_22 · Cited by 4
Muscle invasive bladder cancer and radical cystectomy: a risk predictive model
Tfaily, M. A., Tamim, H., Hajj, A. E., & Mukherji, D. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1456 · Cited by 4
Hall, T. S., Herrscher, T. E., Jarolı́m, P., Fagerland, M. W., Jensen, T., Agewall, S., Atar, D., & Hallén, J. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.03.008 · Cited by 5
Subgroup specific incremental value of new markers for risk prediction
Zhou, Q. M., Zheng, Y., & Cai, T. (2012) · Lifetime Data Analysis · doi:10.1007/s10985-012-9235-3 · Cited by 4
Biomarkers for Predicting Postmenopausal Coronary Heart Disease
Spoletini, I., Vitale, C., & Rosano, G. M. C. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.51 · Cited by 4
Aterosclerosis en la mujer: factores de riesgo y prevención
Sonia Kunstmann, F., de Grazia, R., & Daniela Gainza, K. (2012) · Revista chilena de cardiología · doi:10.4067/s0718-85602012000200009 · Cited by 4
Biomarkers and Bioassays for Cardiovascular Diseases: Present and Future
Sim, D., Lieu, H. D., & André, P. (2008) · Biomarker Insights · doi:10.1177/117727190800300001 · Cited by 4
C- Reactive Protein in Tuberculosis and Human Immunodeficiency Virus Infections in Abeokuta, Nigeria
Ojo, D., Jacob, S., & Ayolabi, C. (2012) · Bayero Journal of Pure and Applied Sciences · doi:10.4314/bajopas.v4i2.18 · Cited by 4
Identifying obese women most at risk from cardiovascular disease
Tonstad, S. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803732 · Cited by 4
Schwarzer, R., Schnell‐Inderst, P., Grabein, K., Göhler, A., Stollenwerk, B., Grandi, N. C., Klauß, V., Wasem, J., & Siebert, U. (2009) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2009.05.020 · Cited by 4
Management of Cardiovascular Disease in Women
Mieszczanska, H. Z., & Velarde, G. P. (2014) · Springer eBooks · doi:10.1007/978-1-4471-5517-1 · Cited by 3
¿Cuál es el riesgo cardiovascular del adulto asintomático?
Romero, T. E. (2012) · Revista chilena de cardiología · doi:10.4067/s0718-85602012000200008 · Cited by 3
High sensitive CRP as a predictor of Coronary Artery Disease Severity on Coronary Angiography
Hawezy, A. A., Yousif, S. H., Al-Naqshbandi, A. A., & Bakir, S. H. (2019) · Diyala Journal of Medicine · doi:10.26505/djm.17024630421 · Cited by 3
Metadata
- Authors
- Cook, N. R., Buring, J. E., & Ridker, P. M.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2006-07-04
- Volume
- 145
- Issue
- 1
- Pages
- 21-29
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2100083473
- Cited by
- 504
- References
- 50
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 10 · 2022: 9 · 2021: 11 · 2020: 7 · 2019: 13 · 2018: 14 · 2017: 9 · 2016: 19 · 2015: 23 · 2014: 21 · 2013: 31 · 2012: 35
- FWCI
- 58.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCLA - Biblioteca de Ciencias de la Salud (submittedVersion)
- Funders
- National Institutes of Health (5r01hl043851-10)
- National Heart, Lung, and Blood Institute (HL43851)
- National Cancer Institute (CA-47988, R01CA047988)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- high-sensitivity C-reactive protein, cardiovascular risk prediction, women, 10-year cardiovascular risk, risk reclassification, model discrimination, concordance index, myocardial infarction, stroke, cardiovascular mortality, Women's Health Study
- MeSH terms
- Age Factors, Blood Pressure, C-Reactive Protein, Cardiovascular Diseases, Female, Humans, Lipids, Middle Aged, Smoking, United States, Cohort Studies, Biomarkers, Proportional Hazards Models, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review